Clinical Observational Registry of Patients With Left Bundle Branch Block
Launched by AZIENDA OSPEDALIERO UNIVERSITARIA DI SASSARI · Mar 12, 2022
Trial Information
Current as of August 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at patients who have a condition called Left Bundle Branch Block (LBBB), which can be seen on an electrocardiogram (ECG). LBBB can sometimes lead to heart problems, including a decrease in the heart's ability to pump effectively, known as left ventricular systolic dysfunction. The study aims to understand more about the characteristics of patients with LBBB, identify factors that may predict heart issues, and gather information that could help in managing their treatment.
If you are between the ages of 65 and 74 and have been diagnosed with LBBB on your ECG, you might be eligible to participate. However, those with a history of certain heart conditions, previous heart surgeries, or specific heart devices may not qualify. Participants in the trial will be asked to share their health information, which will help researchers learn more about how LBBB affects patients and how to improve care for those living with this condition. It’s an opportunity to contribute to heart health research while receiving close monitoring of your health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • LBBB on ECG
- Exclusion Criteria:
- • Previous extensive anterior myocardial infarction
- • Previous cardiac surgery or transcatheter aortic valve implantation (TAVI)
- • Congenital structural heart disease
- • Patients implanted with permanent right ventricular stimulation devices and permanent pacing
- • Denial to consent
About Azienda Ospedaliero Universitaria Di Sassari
Azienda Ospedaliero Universitaria di Sassari is a leading academic hospital in Italy, dedicated to advancing healthcare through innovative clinical research and education. As a prominent institution, it integrates cutting-edge medical practices with robust research initiatives, fostering collaboration among healthcare professionals, researchers, and academic scholars. The organization is committed to improving patient outcomes and contributing to the global medical community by conducting high-quality clinical trials across various therapeutic areas, emphasizing ethical standards and patient safety. With a focus on translating research findings into clinical practice, Azienda Ospedaliero Universitaria di Sassari plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sassari, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials